Skip to main content
Erschienen in: Diabetologia 6/2005

01.06.2005 | Article

Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site

verfasst von: S. S. Chung, H. H. Choi, K. W. Kim, Y. M. Cho, H. K. Lee, K. S. Park

Erschienen in: Diabetologia | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Resistin is an adipokine that might link obesity and insulin resistance. A common polymorphism of the human resistin gene, −420C>G, is a major determinant of plasma resistin concentrations as well as resistin mRNA expression in human adipose tissue. In this study, we investigated the regulatory mechanism by which this polymorphism affects resistin expression.

Methods

Electrophoretic mobility shift assay was performed to identify the transcription factors binding to the −420G region. Transient transfection and reporter assay were used to measure promoter activities of the resistin gene. The binding ability of stimulatory protein 1 (Sp1) in response to adipocyte differentiation or high glucose concentrations was also measured.

Results

Sp1 and stimulatory protein 3 (Sp3) specifically bound to the region around −420G of the human resistin gene. Overexpression of Sp1 increased the promoter activity regardless of −420 genotypes, while the promoter activity of the −420G construct was two-fold higher than that of the −420C construct. In contrast, overexpression of Sp3 scarcely increased the promoter activity. The binding ability of Sp1 to the −420G region was increased in response to adipocyte differentiation. Mithramycin A, an inhibitor of DNA binding of Sp1, reduced the effect of high glucose on transcription induction of the resistin gene in adipocytes.

Conclusions/interpretation

These results suggest that Sp1 is an important factor regulating transcription of human resistin gene. A common polymorphism of the human resistin promoter, −420C>G, is critical for the binding of Sp1 and modulates the transcriptional activity of the resistin gene by changing the binding ability of Sp1. In addition, Sp1 may be involved in the increase of resistin expression by hyperglycaemia.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046–4055CrossRefPubMed Holcomb IN, Kabakoff RC, Chan B et al (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046–4055CrossRefPubMed
2.
Zurück zum Zitat Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252–11256CrossRefPubMed Kim KH, Lee K, Moon YS, Sul HS (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem 276:11252–11256CrossRefPubMed
3.
Zurück zum Zitat Steppan CM, Brown EJ, Wright CM et al (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98:502–506CrossRefPubMed Steppan CM, Brown EJ, Wright CM et al (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A 98:502–506CrossRefPubMed
4.
Zurück zum Zitat Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMed Steppan CM, Bailey ST, Bhat S et al (2001) The hormone resistin links obesity to diabetes. Nature 409:307–312CrossRefPubMed
5.
Zurück zum Zitat Pravenec M, Kazdova L, Landa V et al (2003) Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 278:45209–45215CrossRefPubMed Pravenec M, Kazdova L, Landa V et al (2003) Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 278:45209–45215CrossRefPubMed
6.
Zurück zum Zitat Ukkola O (2002) Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 147:571–574CrossRefPubMed Ukkola O (2002) Resistin—a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 147:571–574CrossRefPubMed
7.
Zurück zum Zitat Way JM, Gorgun CZ, Tong Q et al (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276:25651–25653CrossRefPubMed Way JM, Gorgun CZ, Tong Q et al (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 276:25651–25653CrossRefPubMed
8.
Zurück zum Zitat Juan CC, Au LC, Fang VS et al (2001) Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 289:1328–1333CrossRefPubMed Juan CC, Au LC, Fang VS et al (2001) Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 289:1328–1333CrossRefPubMed
9.
Zurück zum Zitat Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561–564CrossRefPubMed Nagaev I, Smith U (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun 285:561–564CrossRefPubMed
10.
Zurück zum Zitat Savage DB, Sewter CP, Klenk ES et al (2001) Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199–2202PubMed Savage DB, Sewter CP, Klenk ES et al (2001) Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 50:2199–2202PubMed
11.
Zurück zum Zitat Youn BS, Yu KY, Park HJ et al (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150–156CrossRefPubMed Youn BS, Yu KY, Park HJ et al (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J Clin Endocrinol Metab 89:150–156CrossRefPubMed
12.
Zurück zum Zitat Banerjee RR, Rangwala SM, Shapiro JS et al (2004) Regulation of fasted blood glucose by resistin. Science 303:1195–1198CrossRefPubMed Banerjee RR, Rangwala SM, Shapiro JS et al (2004) Regulation of fasted blood glucose by resistin. Science 303:1195–1198CrossRefPubMed
13.
Zurück zum Zitat Felipe F, Bonet ML, Ribot J, Palou A (2004) Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53:882–889PubMed Felipe F, Bonet ML, Ribot J, Palou A (2004) Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53:882–889PubMed
14.
Zurück zum Zitat Li Y, Lazar MA (2002) Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Mol Endocrinol 16:1040–1048CrossRefPubMed Li Y, Lazar MA (2002) Differential gene regulation by PPARgamma agonist and constitutively active PPARgamma2. Mol Endocrinol 16:1040–1048CrossRefPubMed
15.
Zurück zum Zitat Kawashima J, Tsuruzoe K, Motoshima H et al (2003) Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 46:231–240PubMed Kawashima J, Tsuruzoe K, Motoshima H et al (2003) Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 46:231–240PubMed
16.
Zurück zum Zitat Rajala MW, Qi Y, Patel HR et al (2004) Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53:1671–1679PubMed Rajala MW, Qi Y, Patel HR et al (2004) Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53:1671–1679PubMed
17.
Zurück zum Zitat Shojima N, Sakoda H, Ogihara T et al (2002) Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 51:1737–1744PubMed Shojima N, Sakoda H, Ogihara T et al (2002) Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 51:1737–1744PubMed
18.
Zurück zum Zitat Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA (2002) Mechanisms regulating adipocyte expression of resistin. J Biol Chem 277:19754–19761CrossRefPubMed Hartman HB, Hu X, Tyler KX, Dalal CK, Lazar MA (2002) Mechanisms regulating adipocyte expression of resistin. J Biol Chem 277:19754–19761CrossRefPubMed
19.
Zurück zum Zitat Seo JB, Noh MJ, Yoo EJ et al (2003) Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Mol Endocrinol 17:1522–1533CrossRef Seo JB, Noh MJ, Yoo EJ et al (2003) Functional characterization of the human resistin promoter with adipocyte determination- and differentiation-dependent factor 1/sterol regulatory element binding protein 1c and CCAAT enhancer binding protein-alpha. Mol Endocrinol 17:1522–1533CrossRef
20.
Zurück zum Zitat Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611–1618PubMed Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611–1618PubMed
21.
Zurück zum Zitat Cho YM, Youn BS, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559–565PubMed Cho YM, Youn BS, Chung SS et al (2004) Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559–565PubMed
22.
Zurück zum Zitat Bouwman P, Philipsen S (2002) Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195:27–38CrossRefPubMed Bouwman P, Philipsen S (2002) Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195:27–38CrossRefPubMed
23.
Zurück zum Zitat Bigger CB, Melnikova IN, Gardner PD (1997) Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene. J Biol Chem 272:25976–25982CrossRefPubMed Bigger CB, Melnikova IN, Gardner PD (1997) Sp1 and Sp3 regulate expression of the neuronal nicotinic acetylcholine receptor beta4 subunit gene. J Biol Chem 272:25976–25982CrossRefPubMed
24.
Zurück zum Zitat Ko JL, Liu HC, Minnerath SR, Loh HH (1998) Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem 273:27678–27685CrossRefPubMed Ko JL, Liu HC, Minnerath SR, Loh HH (1998) Transcriptional regulation of mouse mu-opioid receptor gene. J Biol Chem 273:27678–27685CrossRefPubMed
25.
Zurück zum Zitat Yu JH, Schwartzbauer G, Kazlman A, Menon RK (1999) Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J Biol Chem 274:34327–34336CrossRefPubMed Yu JH, Schwartzbauer G, Kazlman A, Menon RK (1999) Role of the Sp family of transcription factors in the ontogeny of growth hormone receptor gene expression. J Biol Chem 274:34327–34336CrossRefPubMed
26.
Zurück zum Zitat Park KK, Rue SW, Lee IS et al (2003) Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. Biochem Biophys Res Commun 306:239–243CrossRefPubMed Park KK, Rue SW, Lee IS et al (2003) Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. Biochem Biophys Res Commun 306:239–243CrossRefPubMed
27.
Zurück zum Zitat Won J, Yim J, Kim TK (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 277:38230–38238CrossRefPubMed Won J, Yim J, Kim TK (2002) Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 277:38230–38238CrossRefPubMed
28.
Zurück zum Zitat Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489PubMed Dignam JD, Lebovitz RM, Roeder RG (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475–1489PubMed
29.
Zurück zum Zitat Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88:1613–1621PubMed Blume SW, Snyder RC, Ray R, Thomas S, Koller CA, Miller DM (1991) Mithramycin inhibits SP1 binding and selectively inhibits transcriptional activity of the dihydrofolate reductase gene in vitro and in vivo. J Clin Invest 88:1613–1621PubMed
30.
Zurück zum Zitat Engert JC, Vohl MC, Williams SM et al (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51:1629–1634PubMed Engert JC, Vohl MC, Williams SM et al (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51:1629–1634PubMed
31.
Zurück zum Zitat Yu B, Datta PK, Bagchi S (2003) Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31:5368–5376CrossRefPubMed Yu B, Datta PK, Bagchi S (2003) Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites. Nucleic Acids Res 31:5368–5376CrossRefPubMed
32.
Zurück zum Zitat Hansen TO, Bundgaard JR, Nielsen FC, Rehfeld JF (1999) Composite action of three GC/GT boxes in the proximal promoter region is important for gastrin gene transcription. Mol Cell Endocrinol 155:1–8CrossRefPubMed Hansen TO, Bundgaard JR, Nielsen FC, Rehfeld JF (1999) Composite action of three GC/GT boxes in the proximal promoter region is important for gastrin gene transcription. Mol Cell Endocrinol 155:1–8CrossRefPubMed
33.
Zurück zum Zitat Zhu Q, Liao K (2000) Differential expression of the adipocyte amino acid transporter is transactivated by SP1 and SP3 during the 3T3-L1 preadipocyte differentiation process. Biochem Biophys Res Commun 271:100–106CrossRefPubMed Zhu Q, Liao K (2000) Differential expression of the adipocyte amino acid transporter is transactivated by SP1 and SP3 during the 3T3-L1 preadipocyte differentiation process. Biochem Biophys Res Commun 271:100–106CrossRefPubMed
34.
Zurück zum Zitat Marinovic AC, Zheng B, Mitch WE, Price SR (2002) Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J Biol Chem 277:16673–16681CrossRefPubMed Marinovic AC, Zheng B, Mitch WE, Price SR (2002) Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J Biol Chem 277:16673–16681CrossRefPubMed
35.
Zurück zum Zitat Chen YQ, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE (1998) Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 273:8225–8231CrossRefPubMed Chen YQ, Su M, Walia RR, Hao Q, Covington JW, Vaughan DE (1998) Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J Biol Chem 273:8225–8231CrossRefPubMed
36.
Zurück zum Zitat Lam JK, Matsubara S, Mihara K, Zheng XL, Mooradian AD, Wong NC (2003) Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry 42:2680–2690CrossRefPubMed Lam JK, Matsubara S, Mihara K, Zheng XL, Mooradian AD, Wong NC (2003) Insulin induction of apolipoprotein AI, role of Sp1. Biochemistry 42:2680–2690CrossRefPubMed
37.
Zurück zum Zitat Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222–12226CrossRefPubMed Du XL, Edelstein D, Rossetti L et al (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222–12226CrossRefPubMed
Metadaten
Titel
Regulation of human resistin gene expression in cell systems: an important role of stimulatory protein 1 interaction with a common promoter polymorphic site
verfasst von
S. S. Chung
H. H. Choi
K. W. Kim
Y. M. Cho
H. K. Lee
K. S. Park
Publikationsdatum
01.06.2005
Erschienen in
Diabetologia / Ausgabe 6/2005
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-005-1762-y

Weitere Artikel der Ausgabe 6/2005

Diabetologia 6/2005 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.